Comparative disposition of (R)-(+)-pulegone in B6C3F1 mice and F344 rats

Drug Metabolism and Disposition

Volumn 31, Issue 7, 2003, Pages 892-899

  Chen, L J ^a   Lebetkin, E H ^a   Burka, L T ^a  

^a NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBON 14; ESSENTIAL OIL; HERBACEOUS AGENT; PULEGONE;

ABORTION; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG DISPOSITION; DRUG DISTRIBUTION; DRUG FECES LEVEL; DRUG METABOLISM; DRUG TISSUE LEVEL; DRUG URINE LEVEL; FEMALE; HYDROXYLATION; ISOTOPE LABELING; MALE; MENSTRUATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; RADIOACTIVITY; RAT; SEX DIFFERENCE; URINARY EXCRETION;

ADMINISTRATION, ORAL; ANIMALS; BILE; BIOTRANSFORMATION; CARBON ISOTOPES; DRUG ADMINISTRATION SCHEDULE; DRUG EVALUATION; FECES; FEMALE; INJECTIONS, INTRAVENOUS; KIDNEY; LIVER; LUNG; MALE; MICE; MICE, INBRED STRAINS; MONOTERPENES; RATS; RATS, INBRED F344; SEX CHARACTERISTICS; SPECIES SPECIFICITY; TISSUE DISTRIBUTION;

ANIMALIA; MENTHA;

EID: 0038650990     PISSN: 00909556     EISSN: None     Source Type: Journal    
DOI: 10.1124/dmd.31.7.892     Document Type: Article

References (17)

1. Anderson IB, Mullen WH, Meeker JE, Khojasteh-Bakht SC, Oishi S, Nelson SD, and Blanc PD (1996) Pennyroyal toxicity: measurement of toxic metabolite levels in two cases and review of the literature. Ann Intern Med 124:726-734.
2. Chen L-J. Lebetkin EH, and Burka LT (2001) Metabolism of (R)-(+)-pulegone in F344 rats. Drug Metab Dispos 29:1567-1577.
3. Franzios G, Mirotsu M, Hatziapostolou E, Kral J, Scouras ZG, and Mavragani-Tsipidou P (1997) Insecticidal and genotoxic activities of mint essential oils. J Agric Food Chem 45:2690-2694.
4. Gibson GG and Skett P (1986) Introduction to Drug Metabolism, pp 255-257, Chapman and Hall, London.
5. Gordon WP, Forte AJ. McMurtry RJ, Gal J, and Nelson SD (1982) Hepatotoxicity and pulmonary toxicity of pennyroyal oil and its constituent terpenes in the mouse. Toxicol Appl Pharmacol 65:413-424.
6. Griffin RJ, Salemme J, Clark J, Myers P, and Burka LT (1997) Biliary elimination of oral 2,4-dichlorophenoxyacetic acid and its metabolites in male and female Sprague-Dawley rats, B6C3F1 mice and Syrian hamsters. J Toxicol Environ Health 51:401-413.
7. Hinchman CA and Ballatori N (1994) Glutathione conjugation and conversion to mercapturic acids can occur as an intrahepatic process. J Toxicol Environ Health 41:387-409.
8. Khojasteh-Bakht SC, Chen W, Koenigs LL, Peter RM, and Nelson SD (1999) Metabolism of (R)-(+)-pulegone and (R)-(+)-menthofuran by human liver cytochrome P-450s: evidence for formation of a furan epoxide. Drug Metab Dispos 27:574-580.
9. Madyastha KM and Raj CP (1990) Biotransformation of R-(+)-pulegone and menthofuran in vitro: chemical basis for toxicity. Biochem Biophys Res Commun 173:1086-1092.
10. McClanahan RH, Thomasson D, Slattery JT, and Nelson SD (1989) Metabolic activation of (R)-(+)-pulegone to a reactive enonal that covalently binds to mouse liver proteins. Chem Res Toxicol 2:349-355.
11. 2u-globulin: role of protein accumulation versus ligand delivery to the kidney, in Species Differences in Thyroid, Kidney and Urinary Bladder Carcinogenesis (Capen CC, Dybing E. Rice JM, and Wilbourn JD eds), pp 119-137, No. 147, IARC Scientific Publications, Lyon.
12. Mizutani T, Nomura H, Nakanishi K, and Fujita S (1987) Effects of drug metabolism modifiers on pulegone-induced hepatotoxicity in mice. Res Commun Chem Pathol Pharmacol 58:75-83.
13. Moorthy B, Madyastha P, and Madyastha KM (1989) Hepatotoxicity of pulegone in rats: its effect on microsomal enzymes, in vivo. Toxicology 55:327-337.
14. Swenberg JA and Lehman-McKeeman (1999) α2-Urinary globulin-associated nephropathy as a mechanism of renal tubule cell carcinogenesis in male rats, in Species Differences in Thyroid, Kidney and Urinary Bladder Carcinogenesis (Capen CC, Dybing E, Rice JM, and Wilbourn JD eds), pp 95-118, No. 147, IARC Scientific Publications, Lyon.
15. Thomassen D, Pearson PG, Slattery JT, and Nelson SD (1991) Partial characterization of biliary metabolites of pulegone by tandem mass spectrometry. Drug Metab Dispos 19:997-1003.
16. Thomassen D, Slattery JT, and Nelson SD (1990) Menthofuran-dependent and independent aspects of pulegone hepatotoxicity: role of glutathione. J Pharmacol Exp Ther 253:567-572.
17. Thorup I, Würtzen J, Carstensen J, and Olsen P (1983) Short term toxicity study in rats dosed with pulegone and menthol. Toxicol Lett (Shannon) 19:207-210.